Statement on "Calcium Substitution and Myocardial Infarction Risk."

messages in brief | 13/08/2010

The Federal Office for Safety in Health Care (BASG) publishes the following statement on "Calcium Supplementation and Myocardial Infarction Risk." It refers to a meta-analysis on the use of calcium as monotherapy for osteoporosis published in the British Medical Journal on July 29, 2010. (Bolland MJ. BMJ 2010;341:c3691(


BASG Opinion:

  • The results of this meta-analysis will possibly influence the recommendation guidelines. In the view of the BASG, the data situation is currently not sufficient for a contraindication of calcium monotherapy for osteoporosis in the SmPC, nor for a mandatory combination with drug-based osteoporosis therapy.
  • A possible change of the wording "prevention of calcium deficiency" in the expert information is currently being clarified by the BASG.
  • AGES, Food Testing Division, will inform the Codex Subcommittee on Food Supplements to prepare a national position. This position will serve as a basis for activities of the Federal Ministry of Health at national level and in the relevant EU bodies.
  • The BASG recommends against uncritical prophylactic calcium supplementation for safety reasons.




Dr. Marcus Müllner




Further inquiry note